Rapafusyn Pharmaceuticals
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · Maryland, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
855 N Wolfe St Fl Ground Ste B, Baltimor...Phone Number
(410) 995-8234Website
www.rapafusyn.comRevenue
$6.4 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
1
1
1
About Rapafusyn Pharmaceuticals
Rapafusyn Pharmaceuticals is a pioneering biotechnology company focusing on the development of RapaGlues, innovative non-degrading molecular glues that target otherwise intractable proteins. Their platform is designed to inhibit a wide range of intracellular and transmembrane targets, making them suitable for various therapeutic areas, including oncology, immunology, and acute kidney injury. The company's lead candidate, RAP-0001, is a selective ENT1 inhibitor aimed at protecting renal function during cardiac surgery. Rapafusyn is actively seeking partnerships to accelerate the development of its groundbreaking therapies.Explore more
Rapafusyn Pharmaceuticals Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Rapafusyn Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Rapafusyn Pharmaceuticals had a recent Job posting/layoffs
Earning: See what the market has to say on Rapafusyn Pharmaceuticals recently announced quarterly report
Funding: Get notified immidiatlly once Rapafusyn Pharmaceuticals has new funding data
Check if Rapafusyn Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Rapafusyn Pharmaceuticals
Website visits: Recent activity has been detected on your website
Rapafusyn Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Rapafusyn Pharmaceuticals is spiking on competitors!
Product Launch: Get notified when Rapafusyn Pharmaceuticals launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to Rapafusyn Pharmaceuticals
Compare insights from companies similar to Rapafusyn Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Rapafusyn Pharmaceuticals is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Rapafusyn Pharmaceuticals is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Rapafusyn Pharmaceuticals.
Rapafusyn Pharmaceuticals financials insights
Gather financial insights about Rapafusyn Pharmaceuticals, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2025
Series A
$44M
Rapafusyn Pharmaceuticals Tech Stack
A closer look at the technologies used by Rapafusyn Pharmaceuticals
Most Recent Scoops
Funding
Funding
Event
Product Marketing, Events, Sales, Food & Beverage, Hospitality, Field /Outside Sales, Field Marketing
Funding
Funding
Event
Events
Rapafusyn Pharmaceuticals News & Media
Rapafusyn Pharmaceuticals Closes Over-Subscribed $44 Million Series A Financing to Advance Its Non-Degrading Molecular Glue Drug Discovery Platform
BioTrack Capital and Yonjin Capital join Series A round alongside other investors including 3E Bioventures Capital, Proxima Ventures Ltd., and Lapam CapitalRapafusyn Pharmaceuticals to Showcase Its Molecular Glue Drug Discovery Platform at WuXi Global Forum
BALTIMORE, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Rapafusyn Pharmaceuticals, a pioneer in non-degrading molecular glue therapeutics, announced today that it will host an executive roundtable at the WuXi Global Forum on January 14, 2025, in San Francisco, California.Rapafusyn Announces an Upcoming Oral Presentation at Targeted Protein Degradation & Induced Proximity Summit
BALTIMORE, Oct. 23, 2024 (GLOBE NEWSWIRE) -- Rapafusyn Pharmaceuticals is pleased to announce an upcoming oral presentation at the 7th Targeted Protein Degradation & Induced Proximity Summit taking place from October 28-31, 2024 in Boston, MA.
Read more news
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Rapafusyn Pharmaceuticals
Sign Up For FreeTo access detailed company insights
Rapafusyn Pharmaceuticals is a pioneering biotechnology company focusing on the development of RapaGlues, innovative non-degrading molecular glues that target otherwise intractable proteins. Their platform is designed to inhibit a wide range of intracellular and transmembrane targets, making them suitable for various therapeutic areas, including on... Read More
